Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
The global hematology market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. The growth of the hematology analyzers and reagents market is driven by factors such as increasing adoption of automated hematology instruments by diagnostics laboratories, growing development of the high throughput hematology analyzers, integration of basic flow-cytometry techniques in modern hematology analyzers, developments in high sensitivity Point-of-Care hematology testing, and the introduction of technologically advanced hematology instruments. However, slow adoption of advanced hematology instruments in the emerging economies, hematology product recalls, and the high cost of hematology analyzers are restraining the growth of this market. Rapid growth of hematology market in emerging countries such as India, China and Brazil; introduction of digital imaging systems in hematology laboratories; and growing use of microfluidics technology in hematology analyzer are creating opportunities for the growth of the hematology analyzers and reagents market in these regions.
In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). The hematology consumables market accounts for the largest share of the global hematology analyzers and reagents market in 2014. Factors such as new product launches, development of high throughput screening techniques, and increasing adoption of hematology automation platforms in laboratories are stimulating the growth of the hematology reagents market.
Geographically, North America commands the largest share of 44% of the global hematology analyzers and reagents market in 2014, followed by Europe. The hematology analyzers and reagents market in the North America is primarily driven by various factors including technological advancements, rising incidence/prevalence of patients suffering from blood disorders, increasing funding to research institutes, and presence of large number of well established hematology firms. However, increasing government pressure to reduce the healthcare cost, decreasing reimbursement of laboratory tests, and rising price pressure on the market players are restraining the growth of the market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 9.4% in the next five years, owing to factors such as large patient population, increasing funding/investment toward the development of hematology products, and growing focus of both international and domestic players.
The global hematology analyzers and reagents market is highly competitive with a large number of big and small market players. As of 2013, the global hematology analyzers and reagents market was dominated by Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), and Abbott Laboratories (U.S.), which together accounted for 83% of the market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the hematology analyzers and reagents market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and Porter’s five force model), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the hematology analyzers and reagents market, high-growth regions/countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
In this report, the global hematology market has been segmented on the basis of type of product (hematology instruments and consumables) & services and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs). The hematology consumables market accounts for the largest share of the global hematology analyzers and reagents market in 2014. Factors such as new product launches, development of high throughput screening techniques, and increasing adoption of hematology automation platforms in laboratories are stimulating the growth of the hematology reagents market.
Geographically, North America commands the largest share of 44% of the global hematology analyzers and reagents market in 2014, followed by Europe. The hematology analyzers and reagents market in the North America is primarily driven by various factors including technological advancements, rising incidence/prevalence of patients suffering from blood disorders, increasing funding to research institutes, and presence of large number of well established hematology firms. However, increasing government pressure to reduce the healthcare cost, decreasing reimbursement of laboratory tests, and rising price pressure on the market players are restraining the growth of the market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 9.4% in the next five years, owing to factors such as large patient population, increasing funding/investment toward the development of hematology products, and growing focus of both international and domestic players.
The global hematology analyzers and reagents market is highly competitive with a large number of big and small market players. As of 2013, the global hematology analyzers and reagents market was dominated by Sysmex Corporation (Japan), Beckman Coulter, Inc. (U.S.), and Abbott Laboratories (U.S.), which together accounted for 83% of the market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the hematology analyzers and reagents market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and Porter’s five force model), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the hematology analyzers and reagents market, high-growth regions/countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on hematology analyzers and reagents offered by the top 10 players in the hematology analyzers and reagents market. The report analyzes the hematology analyzers and reagents market by type of product and surgery across geographies
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the hematology analyzers and reagents market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hematology analyzers and reagents across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hematology analyzers and reagents market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the hematology analyzers and reagents market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 MARKET SCOPE
1.6 RESEARCH METHODOLOGY
1.6.1 MARKET SIZE ESTIMATION
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION
1.6.3 MARKET SHARE ESTIMATION
1.6.4 KEY DATA FROM SECONDARY SOURCES
1.6.5 KEY DATA FROM PRIMARY SOURCES
1.6.6 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
3.1 GLOBAL HEMATOLOGY MARKET, BY PRODUCT
3.2 HEMATOLOGY MARKET, BY REGION AND PRODUCTS
3.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION AND END USER
3.4 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION AND REGION
3.5 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY TYPE OF PRODUCT AND REGION
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET SEGMENTATION
4.2.1 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE
4.2.2 HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY
4.2.3 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION
4.2.4 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE
4.2.5 HEMATOLOGY CONSUMABLES MARKET, BY TYPE
4.2.6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
4.2.7 HEMOSTASIS MARKET, BY PRODUCT
4.2.8 IMMUNOHEMATOLOGY MARKET, BY PRODUCT
4.2.9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY
4.3 MARKET DYNAMICS
4.3.1 MARKET DRIVERS
4.3.1.1 Development of high throughput hematology analyzers
4.3.1.2 Increasing usage of basic flow cytometry techniques in modern hematology Analyzers
4.3.1.3 Increasing adoption of automated hematology instruments by diagnostic laboratories
4.3.1.4 Technological advancements
4.3.1.5 Development of high-sensitivity point-of-care (POC) hematology testing
4.3.2 RESTRAINTS
4.3.2.1 Slow adoption of advanced hematology instruments in emerging economies
4.3.2.2 Hematology product recalls
4.3.2.3 High cost of hematology analyzers
4.3.3 OPPORTUNITIES
4.3.3.1 Introduction of digital imaging systems in hematology laboratories
4.3.3.2 Growing use of microfluidics technology in hematology analyzers
4.3.3.3 Rapid growth of hematology market in emerging countries such as India, China, and Brazil in the future
4.3.4 CHALLENGES
4.3.4.1 Sustainability of players in the highly competitive market
4.3.4.2 Stringent and time-consuming regulatory policies
5 INDUSTRY ANALYSIS
5.1 INTRODUCTION
5.2 SUPPLY CHAIN ANALYSIS
5.2.1 KEY INFLUENCERS
5.2.2 PORTER’S FIVE FORCES ANALYSIS
5.2.2.1 Threat from new entrants
5.2.2.2 Threat from substitutes
5.2.2.3 Bargaining power of suppliers
5.2.2.4 Bargaining power of buyers
5.2.2.5 Intensity of competitive rivalry
5.3 INDUSTRY TRENDS
5.3.1 PARTNERSHIPS AMONG HEMATOLOGY INSTRUMENTS AND CONSUMABLES MANUFACTURERS
5.3.2 ACQUISITION OF SMALL PLAYERS
5.3.3 INCREASING FOCUS TOWARDS REAGENT RENTAL BUSINESS
6 HEMATOLOGY PRODUCTS AND SERVICES MARKET
6.1 INTRODUCTION
6.2 HEMATOLOGY PRODUCTS MARKET
6.2.1 HEMATOLOGY INSTRUMENTS
6.2.1.1 Hematology analyzers
6.2.1.2 Hematology analyzers market, by type of automation
6.2.1.2.1 Fully automated hematology analyzers
6.2.1.2.1.1 5-part and 6-part differential hematology analyzers
6.2.1.2.1.2 3-part differential hematology analyzers
6.2.1.2.2 Semi-automated hematology analyzers
6.2.1.3 Hematology analyzers, by complexity
6.2.1.3.1 Highly complex clinical laboratory analyzers
6.2.1.3.2 Hematology analyzers for point-of-care testing
6.2.1.4 Hematology analyzers, by price range
6.2.1.4.1 High-end hematology analyzers
6.2.1.4.2 Low-range and mid-range hematology analyzers
6.2.1.5 Slide stainers/makers
6.2.2 HEMATOLOGY CONSUMABLES
6.2.2.1 Hematology reagents
6.2.2.2 Hematology stains
6.2.2.3 Controls and calibrators
6.3 SERVICES
6.4 HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET
6.4.1 INTRODUCTION
6.4.2 HEMOSTASIS INSTRUMENTS
6.4.3 HEMOSTASIS REAGENTS
6.5 IMMUNOHEMATOLOGY INSTRUMENTS AND REAGENTS MARKET
6.5.1 INTRODUCTION
6.5.2 IMMUNOHEMATOLOGY INSTRUMENTS
6.5.3 IMMUNOHEMATOLOGY REAGENTS
7 GLOBAL HEMATOLOGY MARKET, BY END USER
7.1 INTRODUCTION
7.2 CLINICAL TESTING LABORATORIES
7.3 STAND-ALONE HOSPITALS
7.4 RESEARCH INSTITUTIONS
7.4.1 PUBLIC AND PRIVATE RESEARCH CENTERS
7.4.2 ACADEMIC INSTITUTIONS
7.5 COMMERCIAL ORGANIZATIONS
8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA-PACIFIC
8.5 ROW
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS, HEMATOLOGY PRODUCTS AND SERVICES MARKET
9.3 MARKET SHARE ANALYSIS, HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET
9.4 MARKET SHARE ANALYSIS, IMMUNOHEMATOLOGY PRODUCTS AND SERVICES MARKET
9.5 COMPETITIVE SITUATION AND TRENDS
9.5.1 NEW PRODUCT LAUNCHES
9.5.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
9.5.3 MERGERS & ACQUISITIONS
9.5.4 EXPANSIONS
9.5.5 OTHER DEVELOPMENTS
10 COMPANY PROFILES
10.1 SYSMEX CORPORATION
10.2 BECKMAN COULTER, INC.(A SUBSIDIARY OF DANAHER CORPORATION)
10.3 ABBOTT LABORATORIES
10.4 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
10.5 HORIBA, LTD.
10.6 BIO-RAD LABORATORIES, INC.
10.7 BOULE DIAGNOSTICS AB
10.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
10.9 NIHON KOHDEN CORPORATION
10.10 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD)
*Details on Financials, Product & Services, Key Strategy, & Developments might not be captured in case of unlisted companies
* SWOT Analysis and MNM View are provided for top-5 companies only
1.1 OBJECTIVES OF THE STUDY
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 MARKET SCOPE
1.6 RESEARCH METHODOLOGY
1.6.1 MARKET SIZE ESTIMATION
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION
1.6.3 MARKET SHARE ESTIMATION
1.6.4 KEY DATA FROM SECONDARY SOURCES
1.6.5 KEY DATA FROM PRIMARY SOURCES
1.6.6 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
3.1 GLOBAL HEMATOLOGY MARKET, BY PRODUCT
3.2 HEMATOLOGY MARKET, BY REGION AND PRODUCTS
3.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION AND END USER
3.4 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION AND REGION
3.5 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY TYPE OF PRODUCT AND REGION
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET SEGMENTATION
4.2.1 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE
4.2.2 HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY
4.2.3 HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION
4.2.4 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE
4.2.5 HEMATOLOGY CONSUMABLES MARKET, BY TYPE
4.2.6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
4.2.7 HEMOSTASIS MARKET, BY PRODUCT
4.2.8 IMMUNOHEMATOLOGY MARKET, BY PRODUCT
4.2.9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY
4.3 MARKET DYNAMICS
4.3.1 MARKET DRIVERS
4.3.1.1 Development of high throughput hematology analyzers
4.3.1.2 Increasing usage of basic flow cytometry techniques in modern hematology Analyzers
4.3.1.3 Increasing adoption of automated hematology instruments by diagnostic laboratories
4.3.1.4 Technological advancements
4.3.1.5 Development of high-sensitivity point-of-care (POC) hematology testing
4.3.2 RESTRAINTS
4.3.2.1 Slow adoption of advanced hematology instruments in emerging economies
4.3.2.2 Hematology product recalls
4.3.2.3 High cost of hematology analyzers
4.3.3 OPPORTUNITIES
4.3.3.1 Introduction of digital imaging systems in hematology laboratories
4.3.3.2 Growing use of microfluidics technology in hematology analyzers
4.3.3.3 Rapid growth of hematology market in emerging countries such as India, China, and Brazil in the future
4.3.4 CHALLENGES
4.3.4.1 Sustainability of players in the highly competitive market
4.3.4.2 Stringent and time-consuming regulatory policies
5 INDUSTRY ANALYSIS
5.1 INTRODUCTION
5.2 SUPPLY CHAIN ANALYSIS
5.2.1 KEY INFLUENCERS
5.2.2 PORTER’S FIVE FORCES ANALYSIS
5.2.2.1 Threat from new entrants
5.2.2.2 Threat from substitutes
5.2.2.3 Bargaining power of suppliers
5.2.2.4 Bargaining power of buyers
5.2.2.5 Intensity of competitive rivalry
5.3 INDUSTRY TRENDS
5.3.1 PARTNERSHIPS AMONG HEMATOLOGY INSTRUMENTS AND CONSUMABLES MANUFACTURERS
5.3.2 ACQUISITION OF SMALL PLAYERS
5.3.3 INCREASING FOCUS TOWARDS REAGENT RENTAL BUSINESS
6 HEMATOLOGY PRODUCTS AND SERVICES MARKET
6.1 INTRODUCTION
6.2 HEMATOLOGY PRODUCTS MARKET
6.2.1 HEMATOLOGY INSTRUMENTS
6.2.1.1 Hematology analyzers
6.2.1.2 Hematology analyzers market, by type of automation
6.2.1.2.1 Fully automated hematology analyzers
6.2.1.2.1.1 5-part and 6-part differential hematology analyzers
6.2.1.2.1.2 3-part differential hematology analyzers
6.2.1.2.2 Semi-automated hematology analyzers
6.2.1.3 Hematology analyzers, by complexity
6.2.1.3.1 Highly complex clinical laboratory analyzers
6.2.1.3.2 Hematology analyzers for point-of-care testing
6.2.1.4 Hematology analyzers, by price range
6.2.1.4.1 High-end hematology analyzers
6.2.1.4.2 Low-range and mid-range hematology analyzers
6.2.1.5 Slide stainers/makers
6.2.2 HEMATOLOGY CONSUMABLES
6.2.2.1 Hematology reagents
6.2.2.2 Hematology stains
6.2.2.3 Controls and calibrators
6.3 SERVICES
6.4 HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET
6.4.1 INTRODUCTION
6.4.2 HEMOSTASIS INSTRUMENTS
6.4.3 HEMOSTASIS REAGENTS
6.5 IMMUNOHEMATOLOGY INSTRUMENTS AND REAGENTS MARKET
6.5.1 INTRODUCTION
6.5.2 IMMUNOHEMATOLOGY INSTRUMENTS
6.5.3 IMMUNOHEMATOLOGY REAGENTS
7 GLOBAL HEMATOLOGY MARKET, BY END USER
7.1 INTRODUCTION
7.2 CLINICAL TESTING LABORATORIES
7.3 STAND-ALONE HOSPITALS
7.4 RESEARCH INSTITUTIONS
7.4.1 PUBLIC AND PRIVATE RESEARCH CENTERS
7.4.2 ACADEMIC INSTITUTIONS
7.5 COMMERCIAL ORGANIZATIONS
8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA-PACIFIC
8.5 ROW
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS, HEMATOLOGY PRODUCTS AND SERVICES MARKET
9.3 MARKET SHARE ANALYSIS, HEMOSTASIS INSTRUMENTS AND REAGENTS MARKET
9.4 MARKET SHARE ANALYSIS, IMMUNOHEMATOLOGY PRODUCTS AND SERVICES MARKET
9.5 COMPETITIVE SITUATION AND TRENDS
9.5.1 NEW PRODUCT LAUNCHES
9.5.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
9.5.3 MERGERS & ACQUISITIONS
9.5.4 EXPANSIONS
9.5.5 OTHER DEVELOPMENTS
10 COMPANY PROFILES
10.1 SYSMEX CORPORATION
10.2 BECKMAN COULTER, INC.(A SUBSIDIARY OF DANAHER CORPORATION)
10.3 ABBOTT LABORATORIES
10.4 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
10.5 HORIBA, LTD.
10.6 BIO-RAD LABORATORIES, INC.
10.7 BOULE DIAGNOSTICS AB
10.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
10.9 NIHON KOHDEN CORPORATION
10.10 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD)
*Details on Financials, Product & Services, Key Strategy, & Developments might not be captured in case of unlisted companies
* SWOT Analysis and MNM View are provided for top-5 companies only
LIST OF TABLES
TABLE 1 GLOBAL HEMATOLOGY PRODUCTS MARKET, BY SEGMENT, 2012–2019 ($MILLION)
TABLE 2 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 3 HEMATOLOGY PRODUCTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 4 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 5 GLOBAL HEMATOLOGY INSTRUMENTS MARKET, 2012–2019 ($MILLION)
TABLE 6 HEMATOLOGY INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 7 HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 8 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 9 GLOBAL FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 10 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 11 5-PART AND 6-PART HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 12 3-PART DIFFERENTIAL HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 13 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 14 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY, 2012–2019 ($MILLION)
TABLE 15 HIGHLY COMPLEX CLINICAL LABORATORY HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 16 HEMATOLOGY ANALYZERS FOR POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 17 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE, 2012–2019 ($MILLION)
TABLE 18 HIGH-END HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 19 LOW- AND MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 20 HEMATOLOGY SLIDE STAINERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 21 GLOBAL HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 22 GLOBAL HEMATOLOGY REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 23 HEMATOLOGY STAINS MARKET, BY GEOGRAPHY, 2012 – 2019 ($MILLION)
TABLE 24 GLOBAL HEMATOLOGY CONTROLS AND CALIBRATORS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 25 HEMATOLOGY SERVICE MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 26 GLOBAL HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 27 HEMOSTASIS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 28 HEMOSTASIS INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 29 HEMOSTASIS REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 30 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 31 GLOBAL IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION)
TABLE 32 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 33 IMMUNOHEMATOLOGY REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 34 GLOBAL HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 35 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USERS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 36 HEMATOLOGY MARKET FOR CLINICAL TESTING LABORATORIES, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 37 HEMATOLOGY MARKET FOR STANDALONE HOSPITALS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 38 GLOBAL HEMATOLOGY MARKET FOR RESEARCH INSTITUTIONS, BY END USER, 2012–2019 ($MILLION)
TABLE 39 HEMATOLOGY MARKET FOR RESEARCH INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 40 HEMATOLOGY MARKET FOR PUBLIC AND PRIVATE RESEARCH CENTERS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 41 HEMATOLOGY MARKET FOR ACADEMIC INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 42 HEMATOLOGY MARKET FOR COMMERCIAL ORGANIZATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 43 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 44 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 45 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 46 NORTH AMERICA: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 47 NORTH AMERICA: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 48 NORTH AMERICA: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 49 NORTH AMERICA: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 50 NORTH AMERICA: IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION)
TABLE 51 NORTH AMERICA: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 52 EUROPE: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 53 EUROPE: HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 54 EUROPE: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 55 EUROPE: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 56 EUROPE: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 57 EUROPE: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 58 EUROPE: IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION)
TABLE 59 EUROPE: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 60 ASIA-PACIFIC: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 61 ASIA-PACIFIC: HEMATOLOGY PRODUCTS MARKET, 2012–2019 ($MILLION)
TABLE 62 ASIA-PACIFIC: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 63 ASIA-PACIFIC: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 64 ASIA-PACIFIC: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 65 ASIA-PACIFIC: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 66 ASIA-PACIFIC: IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012-2019 ($MILLION)
TABLE 67 ASIA-PACIFIC: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 68 ROW: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012– 2019 ($MILLION)
TABLE 69 ROW: HEMATOLOGY PRODUCTS MARKET, BY SEGMENT, 2012–2019 ($MILLION)
TABLE 70 ROW: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 71 ROW: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 72 ROW: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 73 ROW: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 74 ROW: IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 75 ROW: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 76 NEW PRODUCT LAUNCHES, 2011–2014
TABLE 77 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES, 2011–2014
TABLE 78 MERGERS & ACQUISITIONS, 2011–2014
TABLE 79 EXPANSIONS, 2011–2014
TABLE 80 OTHER DEVELOPMENTS, 2011–2014
TABLE 1 GLOBAL HEMATOLOGY PRODUCTS MARKET, BY SEGMENT, 2012–2019 ($MILLION)
TABLE 2 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 3 HEMATOLOGY PRODUCTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 4 GLOBAL HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 5 GLOBAL HEMATOLOGY INSTRUMENTS MARKET, 2012–2019 ($MILLION)
TABLE 6 HEMATOLOGY INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 7 HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 8 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 9 GLOBAL FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 10 FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 11 5-PART AND 6-PART HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 12 3-PART DIFFERENTIAL HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 13 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 14 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY COMPLEXITY, 2012–2019 ($MILLION)
TABLE 15 HIGHLY COMPLEX CLINICAL LABORATORY HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 16 HEMATOLOGY ANALYZERS FOR POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 17 GLOBAL HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE, 2012–2019 ($MILLION)
TABLE 18 HIGH-END HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 19 LOW- AND MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 20 HEMATOLOGY SLIDE STAINERS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 21 GLOBAL HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 22 GLOBAL HEMATOLOGY REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 23 HEMATOLOGY STAINS MARKET, BY GEOGRAPHY, 2012 – 2019 ($MILLION)
TABLE 24 GLOBAL HEMATOLOGY CONTROLS AND CALIBRATORS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 25 HEMATOLOGY SERVICE MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 26 GLOBAL HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 27 HEMOSTASIS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 28 HEMOSTASIS INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 29 HEMOSTASIS REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 30 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 31 GLOBAL IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION)
TABLE 32 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 33 IMMUNOHEMATOLOGY REAGENTS MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 34 GLOBAL HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 35 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USERS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 36 HEMATOLOGY MARKET FOR CLINICAL TESTING LABORATORIES, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 37 HEMATOLOGY MARKET FOR STANDALONE HOSPITALS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 38 GLOBAL HEMATOLOGY MARKET FOR RESEARCH INSTITUTIONS, BY END USER, 2012–2019 ($MILLION)
TABLE 39 HEMATOLOGY MARKET FOR RESEARCH INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 40 HEMATOLOGY MARKET FOR PUBLIC AND PRIVATE RESEARCH CENTERS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 41 HEMATOLOGY MARKET FOR ACADEMIC INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 42 HEMATOLOGY MARKET FOR COMMERCIAL ORGANIZATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 43 HEMATOLOGY PRODUCTS AND SERVICES MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 44 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 45 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 46 NORTH AMERICA: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 47 NORTH AMERICA: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 48 NORTH AMERICA: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 49 NORTH AMERICA: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 50 NORTH AMERICA: IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION)
TABLE 51 NORTH AMERICA: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 52 EUROPE: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 53 EUROPE: HEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 54 EUROPE: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 55 EUROPE: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 56 EUROPE: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 57 EUROPE: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 58 EUROPE: IMMUNOHEMATOLOGY MARKET, BY INSTRUMENTS AND REAGENTS, 2012–2019 ($MILLION)
TABLE 59 EUROPE: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 60 ASIA-PACIFIC: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012–2019 ($MILLION)
TABLE 61 ASIA-PACIFIC: HEMATOLOGY PRODUCTS MARKET, 2012–2019 ($MILLION)
TABLE 62 ASIA-PACIFIC: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 63 ASIA-PACIFIC: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 64 ASIA-PACIFIC: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 65 ASIA-PACIFIC: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 66 ASIA-PACIFIC: IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012-2019 ($MILLION)
TABLE 67 ASIA-PACIFIC: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 68 ROW: HEMATOLOGY MARKET, BY PRODUCTS AND SERVICES, 2012– 2019 ($MILLION)
TABLE 69 ROW: HEMATOLOGY PRODUCTS MARKET, BY SEGMENT, 2012–2019 ($MILLION)
TABLE 70 ROW: HEMATOLOGY MARKET, BY INSTRUMENTS, 2012–2019 ($MILLION)
TABLE 71 ROW: HEMATOLOGY ANALYZERS MARKET, BY TYPE OF AUTOMATION, 2012–2019 ($MILLION)
TABLE 72 ROW: HEMATOLOGY CONSUMABLES MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 73 ROW: HEMOSTASIS MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 74 ROW: IMMUNOHEMATOLOGY MARKET, BY PRODUCTS, 2012–2019 ($MILLION)
TABLE 75 ROW: HEMATOLOGY MARKET, BY END USERS, 2012–2019 ($MILLION)
TABLE 76 NEW PRODUCT LAUNCHES, 2011–2014
TABLE 77 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES, 2011–2014
TABLE 78 MERGERS & ACQUISITIONS, 2011–2014
TABLE 79 EXPANSIONS, 2011–2014
TABLE 80 OTHER DEVELOPMENTS, 2011–2014
The global hematology market has been segmented into four broad categories on the basis of the types of end users, namely, clinical testing laboratories, standalone hospitals, research institutions, and commercial organizations.
North America (comprising the U.S. and Canada) accounts for the largest share of XX% of the global hematology market in 2014, followed by Europe with XX%. Factors such as rising prevalence of patients suffering from blood disorders, growing number of surgical procedures including organ transplantations, and the increasing number of life sciences research activities in the U.S. and Canada are driving the growth of the North American hematology analyzers and reagents market. However, ongoing healthcare reforms in the U.S. along with reimbursement cuts are the major factors restraining the growth of the hematology market in North America.
